Cite
HARVARD Citation
Thiem, V. et al. (2021). Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial. Human vaccines & immunotherapeutics. 17 (7), pp. 1980-1985. [Online].